Premium
Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy
Author(s) -
Li SX,
Armstrong AJS,
Neff CP,
Shaffer M,
Lozupone CA,
Palmer BE
Publication year - 2016
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.363
Subject(s) - dysbiosis , microbiome , context (archaeology) , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , gut microbiome , disease , population , medicine , biology , gut flora , viral load , bioinformatics , environmental health , paleontology
Human immunodeficiency virus (HIV) infection is associated with an altered gut microbiome that is not consistently restored with effective antiretroviral therapy (ART). Interpretation of the specific microbiome changes observed during HIV infection is complicated by factors like population, sample type, and ART—each of which may have dramatic effects on gut bacteria. Understanding how these factors shape the microbiome during HIV infection (which we refer to as the HIV‐associated microbiome) is critical for defining its role in HIV disease, and for developing therapies that restore gut health during infection.